Low expression of the cell cycle inhibitor p27(kip1) in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3823-3830

  Lidhar, Kulbir ^a   Korbonits, Márta ^a   Jordan, Suzanne ^a   Khalimova, Zamira ^a,d   Kaltsas, Gregory ^a   Lu, Xin ^c   Clayton, Richard N ^b   Jenkins, Paul J ^a   Monson, John P ^a   Besser, G Michael ^a   Lowe, David G ^a   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d Institute of Endocrinology   (Uzbekistan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ACROMEGALY; ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION;

EID: 0033304951     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6066     Document Type: Article

References (45)

1. Clonal origin of pituitary adenomas
2. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors
3. Pituitary tumor pathogenesis
4. Malignant pituitary tumors
5. 1 phase progression: Cycling on cue
6. 1 cyclin (Cln) function in yeast
7. Effects of an Rb mutation in the mouse
8. Role of cyclin-dependent kinase inhibitors in the development of cancer
9. 1 cyclin-Cdk protein kinase activity, is related to p21
10. Cloning of p57KIP2, a cyclindependent kinase inhibitor with unique domain structure and tissue distribution
11. p27Kip1, A cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
12. Cloning of p27, a cyclln-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
13. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias
14. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
15. Growth suppression by p18, a p16INK4/MTS1- and p04INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
16. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle
17. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
18. Cyclins and cancer
19. Human D-type cyclin
20. Cyclin D1 and oncogenesis
21. Mice lacking p27(Kip1) display Increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
22. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
23. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
24. The murine gene p27(Kip1) is haplo-insufficient for tumor suppression
25. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours
26. Molecular analysis of p21 and p27 genes in human pituitary adenomas
27. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors
28. Transforming growth factor-β, transforming growth factor-βreceptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries
29. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuronendocrine tumors
30. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues
31. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the express ion of p27(kip1) and degree of malignancy in human breast and colorectal cancers
32. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRH, and a cdk inhibitor, p27Kip1, to regions involved in human cancer
33. Aberrant p27kip1 expression in endocrine and other tumors
34. Expression of cell-cycle regulators p27TKip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
35. Decreased levels of the cell cycle inhibitor p27/kip1 protein: Prognostic implications in primary breast cancer
36. Increased proteasome-dependent degradation of the cyclin- dependent kinase inhibitor p27 in aggressive colorectal carcinomas
37. p27 Expression and gastric carcinoma
38. Genomic structure, expression and mutational analysis of the p15 (MTS2) gene
39. Moving protein heads for breakdown
40. 1 is instigated by Jab1
41. Transforming growth factor-β and p27 expression in pituitary cells
42. Corticotroph, somatotroph and mammotroph cell kinetics in the postnatal infant female rat
43. Cushing's disease: A correlation of radiological, surgical and pathological findings with therapeutic results
44. Proliferation parameters for pituitary adenomas